Histological assessment of murine bladder tumors revealed reduced tumor burden and decreased proliferation (Ki67 immunohistochemistry) in muAd-Ifnα treated tumors when compared to Ad-Ctrl treated tumors (Figure 2D; panel H&E and panel Ki67). This evidence concerns the gene MKI67 and urinary bladder neoplasm.